- Home
- NUVB vs STAA Comparison
NUVB vs STAA Comparison
Compare NUVB & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUVB
- STAA
- Stock Information
- Founded
- NUVB 2018
- STAA 1982
- Country
- NUVB United States
- STAA United States
- Employees
- NUVB N/A
- STAA N/A
- Industry
- NUVB Biotechnology: Pharmaceutical Preparations
- STAA Ophthalmic Goods
- Sector
- NUVB Health Care
- STAA Health Care
- Exchange
- NUVB Nasdaq
- STAA Nasdaq
- Market Cap
- NUVB 837.0M
- STAA 915.7M
- IPO Year
- NUVB N/A
- STAA N/A
- Fundamental
- Price
- NUVB $2.75
- STAA $28.37
- Analyst Decision
- NUVB Strong Buy
- STAA Hold
- Analyst Count
- NUVB 6
- STAA 8
- Target Price
- NUVB $8.00
- STAA $22.50
- AVG Volume (30 Days)
- NUVB 4.6M
- STAA 3.4M
- Earning Date
- NUVB 08-07-2025
- STAA 08-06-2025
- Dividend Yield
- NUVB N/A
- STAA N/A
- EPS Growth
- NUVB N/A
- STAA N/A
- EPS
- NUVB N/A
- STAA N/A
- Revenue
- NUVB $14,355,000.00
- STAA $224,449,000.00
- Revenue This Year
- NUVB $98.78
- STAA N/A
- Revenue Next Year
- NUVB $489.71
- STAA $26.12
- P/E Ratio
- NUVB N/A
- STAA N/A
- Revenue Growth
- NUVB 900.35
- STAA N/A
- 52 Week Low
- NUVB $1.54
- STAA $13.50
- 52 Week High
- NUVB $3.46
- STAA $38.60
- Technical
- Relative Strength Index (RSI)
- NUVB 67.35
- STAA 83.25
- Support Level
- NUVB $2.18
- STAA $17.20
- Resistance Level
- NUVB $2.55
- STAA $30.81
- Average True Range (ATR)
- NUVB 0.18
- STAA 0.74
- MACD
- NUVB 0.03
- STAA 0.67
- Stochastic Oscillator
- NUVB 82.48
- STAA 82.07
About NUVB Nuvation Bio Inc.
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.
About STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.